Investorsatril

Investorsatril

Roopa Industries || Details of Business

Roopa Industries Limited

(CIN: L10100AP1985PLC005582)

  • About Us
  • Management
  • Investor Relations
    • Annual Reports
      • Annual Report – 2023-24
      • Annual Report – 2022-23
      • Annual Report – 2021-22
      • Annual Report – 2020-21
      • Annual Report – 2019-20
      • Annual Report – 2018-19
      • Annual Report – 2017-18
      • Annual Report – 2016-17
      • Annual Report – 2015-16
      • Annual Report – 2014-15
    • Annual Return
      • Form MGT-7- Annual Return for FY 2023-24
      • Form MGT-7 – Annual Return for FY 2022-23
      • Form MGT-7 – Annual Return for FY 2021-22
      • Form MGT-7 – Annual Return for FY 2020-21
      • Form MGT-7 – Annual Return for FY 2019-20
      • Form MGT-7 – Annual Return for FY 2018-19
    • Financial Results
      • Q4 Results – FY 2024-25
      • Q3 Results – FY 2024-25
      • Q2 Results – FY 2024-25
      • Q1 Results – FY 2024-25
      • Q4 Results – FY 2023-24
      • Q3 Results – FY 2023-24
      • Q2 Results – FY 2023-24
      • Q1 Results – FY 2023-24
      • Q4 Results – FY 2022-23
      • Q3 Results – FY 2022-23
      • Q2 Results – FY 2022-23
      • Q1 Results – FY 2022-23
      • Q4 Results – FY 2021-22
      • Q3 Results – FY 2021-22
      • Q2 Results – FY 2021-22
      • Q1 Results – FY 2021-22
      • Q4 Results – FY 2020-21
      • Q3 Results – FY 2020-21
      • Q2 Results – FY 2020-21
      • Q1 Results – FY 2020-21
    • Policies & Codes
      • Nomination and Remuneration Policy
      • Policy On Materiality
      • Whistle Blower Policy
      • Terms and Conditions for appointment of Independent Directors
      • Familiarization Programme
      • Policy for Preservation of Documents
      • Code of Conduct for Board and Senior Management
      • Policy for Materiality of Events
    • Investor Information
      • Board Notices
        • Notice of BM on 30-05-2025
        • Notice of BM on 14-02-2025
        • Notice of BM on 14-08-2024
        • Notice of BM on 30-05-2024
        • Notice of BM on 12-02-2024
        • Notice of BM on 14-11-2023
        • Notice of BM on 12-08-2023
        • Notice of BM on 30-05-2023
        • Notice of BM on 14-02-2023
        • Notice of BM on 13-08-2022
        • Notice of BM on 30-05-2022
        • Notice of BM on 12-02-2022
        • Notice of BM on 13-11-2021
        • Notice of BM on 14-08-2021
      • Other Information
        • MOA & AOA
        • Forms for Updation of KYC
        • Letter to Shareholders 05/03/2024
    • AGM/EGM Information
      • AGM
        • 39th AGM – Voting Results
        • 39th AGM Notice for FY 2023-24
        • 38th AGM – Voting Results
        • 38th AGM Notice for FY 2022-23
        • 37th AGM – Voting Results
        • 37th AGM Notice for FY 2021-22
        • 36th AGM – Voting Results
        • 36th AGM Notice for FY 2020-21
        • 35th AGM – Voting Results
        • 35th AGM Notice for FY 2019-20
        • 34th AGM – Voting Results
        • 34th AGM Notice for FY 2018-19
      • EGM
      • Postal Ballot
        • Voting Results of PB dated on 22-08-2022
        • Notice of PB on 19-07-2022
    • Stock Exchange Compliances
      • Shareholding Pattern
        • Q4 SHP – FY 2024-25
        • Q3 SHP – FY 2024-25
        • Q2 SHP – FY 2024-25
        • Q1 SHP – FY 2024-25
        • Q4 SHP – FY 2023-24
        • Q3 SHP – FY 2023-24
        • Q2 SHP – FY 2023-24
        • Q1 SHP – FY 2023-24
        • Q4 SHP – FY 2022-23
        • Q3 SHP – FY 2022-23
        • Q2 SHP – FY 2022-23
        • Q1 SHP – FY 2022-23
        • Q4 SHP – FY 2021-22
        • Q3 SHP – FY 2021-22
        • Q2 SHP – FY 2021-22
        • Q1 SHP – FY 2021-22
      • RSCA
        • Q4 RSCA – FY 2024-25
        • Q3 RSCA – FY 2024-25
        • Q2 RSCA – FY 2024-25
        • Q1 RSCA – FY 2024-25
        • Q4 RSCA – FY 2023-24
        • Q3 RSCA – FY 2023-24
        • Q2 RSCA – FY 2023-24
        • Q1 RSCA – FY 2023-24
        • Q4 RSCA – FY 2022-23
        • Q3 RSCA – FY 2022-23
        • Q2 RSCA – FY 2022-23
        • Q1 RSCA – FY 2022-23
        • Q4 RSCA – FY 2021-22
        • Q3 RSCA – FY 2021-22
        • Q2 RSCA – FY 2021-22
        • Q1 RSCA – FY 2021-22
      • RPT
        • H2 RPT – FY 2023-24
        • H1 RPT – FY 2023-24
        • H2 RPT – FY 2022-23
        • H1 RPT – FY 2022-23
        • H2 RPT – FY 2021-22
        • H1 RPT – FY 2021-22
        • H2 RPT – FY 2020-21
        • H1 RPT – FY 2020-21
        • H2 RPT – FY 2019-20
      • Investor Complaints
        • Q4 ICR – FY 2024-25
        • Q3 ICR – FY 2024-25
        • Q2 ICR – FY 2024-25
        • Q1 ICR – FY 2024-25
        • Q4 ICR – FY 2023-24
        • Q3 ICR – FY 2023-24
        • Q2 ICR – FY 2023-24
        • Q1 ICR – FY 2023-24
        • Q4 ICR – FY 2022-23
        • Q3 ICR – FY 2022-23
        • Q2 ICR – FY 2022-23
        • Q1 ICR – FY 2022-23
        • Q4 ICR – FY 2021-22
        • Q3 ICR – FY 2021-22
        • Q2 ICR – FY 2021-22
        • Q1 ICR – FY 2021-22
    • Newspaper Publications
      • NC – Q4 Results – FY 2024-25
      • NC – Q3 Results – FY 2024-25
      • NC – Q2 Results – FY 2024-25
      • NC – Notice of AGM on 30-09-2024
      • NC – Notice of AGM on 30-09-2023
      • NC – Q1 Results – FY 2024-25
      • NC – Q4 Results – FY 2023-24
      • NC – Q3 Results – FY 2023-24
      • NC – Q2 Results – FY 2023-24
      • NC – Q1 Results – FY 2023-24
      • NC – Q4 Results – FY 2022-23
      • NC – Q3 Results – FY 2022-23
      • NC – Q2 Results – FY 2022-23
      • NC – Notice of AGM on 30-09-2022
      • NC – NBM on 13-08-2022
      • NC – Q1 Results – FY 2022-23
    • Secretarial Compliance Reports
      • SCR FY 2023-24
      • SCR FY 2022-23
      • SCR FY 2021-22
      • SCR FY 2020-21
      • SCR FY 2019-20
  • Contact Us

Code of Conduct

Members of the Board and the Senior Management, shall

  • Always act in the best interests of the Company and its stakeholders.
  • Adopt the highest standards of personal ethics, integrity, confidentiality and discipline in dealing with all matters relating to the company.
  • Apply themselves diligently and objectively in the discharging their responsibilities and contribute to the conduct of the business and progress of the company, and not be associated simultaneously with competing organizations either as a Director or in any managerial or advisory capacity, without the prior approval of the Board.
  • Submit appropriate and fair response to queries on news reports and requests for verification of market rumours by regulatory authorities.
  • Always adhere and conform to the various statutory and mandatory regulations/guidelines applicable to the operations of the company avoiding violations or non-conformities.
  • Nor derive personal benefit or undue advantages (financial or otherwise) by virtue of their position or relationship with the Company, and for this purpose.
    • Shall adopt total transparency in their dealing with the company.
    • Shall disclose full details of any direct or indirect personal interests in dealings/transactions with the company.
    • Shall not be party to transactions or decisions involving conflict between their personal interest and the Company’s interest.
  • Conduct themselves and their activities outside the Company in such manner as not to adversely affect the image or reputation of the Company.
  • Inform the Company immediately if there is any personal development (relating to his/her business/professional activities) which could be incompatible with the level and stature of his position and responsibility with the company.
  • Bring to the attention of the Board, Chairman or the Managing Director as appropriate, any information or development either within the company (relating to its employees or other stakeholders) or external, which could impact the Company’s operations and which in the normal course may not have come to the knowledge of the Board/Chairman or Managing Director.
  • Always abide by the above code of conduct, and shall be accountable to the Board for their actions/violations/ defaults.
20190331-Code-of-Conduct-SEBIPIT-Regulations

© 2025 · Investorsatril · All contents copyright 2011 Roopa Industries. All rights reserved.